Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 13, 2017 - Issue 4
1,627
Views
0
CrossRef citations to date
0
Altmetric
Report

Preliminary Psychometric Evaluation of the Hamilton Depression Rating Scale in Methamphetamine Dependence

, PhD, RN, , BS, , MD, MS, , BA, , PhD, , PhD, , MD, PhD, MBA & , PhD show all

References

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: American Psychiatric Publishing.
  • Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004). The Hamilton Depression Rating Scale: Has the gold standard become a lead weight? American Journal of Psychiatry, 161(12), 2163–2177. doi:10.1176/appi.ajp.161.12.2163
  • Briggs, S. R., & Cheek, J. M. (1986). The role of factor analysis in the development and evaluation of personality scales. Journal of Personality, 54, 106–148.
  • Cronbach, L. J. (1951). Coefficient alpha and the internal structure of tests. Psychometrika, 16(3), 297–334.
  • DiMiceli, L. E., Sherman, S. G., Aramrattana, A., Sirirojn, B., & Celentano, D. D. (2016). Methamphetamine use is associated with high levels of depressive symptoms in adolescents and young adults in Rural Chiang Mai Province, Thailand. BMC Public Health, 16, 168. doi:10.1186/s12889-016-2851-1
  • Glasner-Edwards, S., Mooney, L. J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. (2010). Anxiety disorders among methamphetamine dependent adults: Association with post-treatment functioning. American Journal of Addiction, 19(5), 385–390. doi:10.1111/j.1521-0391.2010.00061.x
  • Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgergy Psychiatry, 23, 56–62.
  • Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the pyschiatric research interview for substance and mental disorders for DSM-IV. American Journal of Psychiatry, 163(4), 689–696.
  • Hasin, D., Trautman, K., & Endicott, J. (1998). Psychiatric research interview for substance and mental disorders: Phenomenologically based diagnosis in patients who abuse alcohol or drugs. Psychopharmacology Bulletin, 34(1), 3–8.
  • Hellem, T. L., Lundberg, K. J., & Renshaw, P. F. (2015). A review of treatment options for co-occurring methamphetamine use disorders and depression. Journal of Addictions Nursing, 26(1), 14–23. doi:10.1097/JAN.0000000000000058
  • Hellem, T. L., Sung, Y. H., Shi, X. F., Pett, M. A., Latendresse, G., Morgan, J., … Renshaw, P. F. (2015). Creatine as a novel treatment for depression in females using methamphetamine: A pilot study. Journal of Dual Diagnosis, 11(3–4), 189–202. doi:10.1080/15504263.2015.1100471
  • Kalechstein, A. D., Newton, T. F., Longshore, D., Anglin, M. D., van Gorp, W. G., & Gawin, F. H. (2000). Psychiatric comorbidity of methamphetamine dependence in a forensic sample. Journal of Neuropsychiatry and Clinical Neuroscience, 12(4), 480–484.
  • Langås, A. M., Malt, U. F., & Opjordsmoen, S. (2011). Comorbid mental disorders in substance users from a single catchment area—a clinical study. BMJ Psychiatry, 11, 25. doi:10.1186/1471-244X-11-25
  • McKetin, R., Lubman, D. I., Lee, N. M., Ross, J. E., & Slade, T. N. (2011). Major depression among methamphetamine users entering drug treatment programs. Medical Journal of Australia, 195(3), S51–S55.
  • Nakama, H., Chang, L., Cloak, C., Jiang, C., Alicata, D., & Haning, W. (2008). Association between psychiatric symptoms and craving in methamphetamine users. American Journal of Addictions, 17, 441–446.
  • Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York, NY: McGraw-Hill.
  • Rawson, R. A. (2013). Current research on the epidemiology, medical and psychiatric effects, and treatment of methamphetamine use. Journal of Food and Drug Analysis, 21(4), S77–S81. doi:10.1016/j.jfda.2013.09.039
  • Santor, D. A., Gregus, M., & Welch, A. (2006). Eight decades of measurement in depression. Measurement, 4(3), 135–155.
  • Semple, S. J., Patterson, T. L., & Rant, I. (2009). Methamphetamine use and depressive symptoms among heterosexual men and women. Journal of Substance Use, 10(1), 31–47. doi:10.1080/1465989042000271264
  • Semple, S. J., Zians, J., Strathdee, S. A., & Patterson, T. L. (2007). Psychosocial and behavioral correlates of depressed mood among female methamphetamine users. Journal of Psychoactive Drugs, Suppl, 4, 353–366.
  • Shoptaw, S., Peck, J., Redbackm, C. J., & Rotheram-Fuller, E. (2003). Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. Journal of Psychoactive Drugs, 35(Suppl 1), 161–168.
  • Stein, M. D., Herman, D. S., Soloman, D. A., Anthony, J. L., Anderson, B. J., Ramsey, S. E., & Miller, I. W. (2004). Adherence to treatment of depression in active injection drug users: The MINERVA study. Journal of Substance Abuse Treatment, 26, 87–93.
  • Sung, Y. H., Yurgelun-Todd, D. A., Shi, X. F., Kondo, D. G., Lundberg, K. J., McGlade, E. C., … Renshaw, P. F. (2013). Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug and Alcohol Dependence, 129(1–2), 102–109. doi:10.1016/j.drugalcdep.2012.09.015
  • Tavakol, M., & Dennick, R. (2011). Making sense of Cronbach's alpha. International Journal of Medical Education, 2, 53–55. doi:10.5116/ijme.4dfb.8dfd
  • Wynn, R., Landheim, A., & Hoxmark, E. (2013). Which factors influence psychiatric diagnosing in substance abuse treatment. International Journal of Mental Health Systems, 7, 17. doi:10.1186/1752-4458-7-1